Please login to the form below

Middle East

This page shows the latest Middle East news and features for those working in and with pharma, biotech and healthcare.

for Europe, Middle East and Africa at Janssen.

Merck signs separate agreements with Seattle Genetics for two cancer drugs

In a separate agreement, Seattle Genetics has granted Merck an exclusive license to commercialise Tukysa (tucatinib), a small molecule tyrosine kinase inhibitor, in Asia, the Middle East, Latin America and other
Takeda to sell Japan consumer health unit for $2.3bn

This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
New coronavirus sees drug developers scramble to develop a vaccine

viruses such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome ( MERS). ... Last week, the first death of a coronavirus patient outside Hubei was confirmed - the patient died in northern Hebei province and another death was
J&J’s new Darzalex formulation OK’d for use in Europe

Every year over 48, 000 people in Europe are diagnosed with multiple myeloma, which is considered to be incurable,” said Patrick Laroche, haematology therapy area lead, Europe, Middle East and Africa
Takeda divests over-the-counter and prescription drugs to Stada for $660m

These markets include Near East, Middle East and Africa (NEMEA) countries. ... It said it plans to divest approximately 30 of its pharmaceutical assets to Acino – the Swiss pharma has a clear focus on selected markets in the Middle East, Africa, the

More from news
Approximately 1 fully matching, plus 132 partially matching documents found.

Unlocking the potential of precision medicine in oncology

More specifically, through our ORACULUM studies, we are using AI to analyse patient-level data that is collected through electronic health records across numerous countries in Europe, the Middle East and
As COVID-19 takes over the world, biopharma fights back

respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
Keeping up the fight against HIV and using the lessons to tackle other threats

their big budget spreadsheets,” said Mike Elliott (pictured above), Vice President of Medical Affairs for Europe, Middle East &Australasia for Gilead Sciences.
Leading AstraZeneca’s return to growth in Europe

Care in Central and Eastern Europe, Middle East and Africa before landing the general manager role in Russia in 2014.
Bluebird: on a mission to ‘recode’ the DNA of healthcare

Obenshain insisted, however, that Bluebird is investing for a long-term independent future, with its sights also set on taking Zynteglo into the Middle East and Asia, where beta thalassemia patients

More from intelligence
Approximately 0 fully matching, plus 31 partially matching documents found.

New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

Umberto La Magna has decided to join Sinclair Pharma, taking up the role of head of Central and Eastern Europe and Middle East and Africa regions. ... Most recently, La Magna held the role of head of central south-east Europe for Baxter International,
Pharnext appoints COO

Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.
Anish Mehta appointed CEO of new women's health business

Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.
Bayer UK and Ireland appoints new CEO

Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.
Paolo Carli appointed as head of MEA at Merck

Middle East, Africa and Turkey (MEA) region.

More from appointments
Approximately 0 fully matching, plus 33 partially matching documents found.

Lucid Group Evolve and Simplify its Brand Architecture

Seven months later, in September 2019, Lucid Group acquired HealthCare21 – increasing its footprint in the UK, Asia Pacific and Middle East along with specific expertise in digital strategy, medical writing, editing
GLOBALHealthPR® Welcomes Exclusive France Partner Agency

GLOBALHealthPR's presence spans more than 60 countries, covering Europe, North America, Latin America, the Middle East, Africa and Asia-Pacific.
It’s Teenage Kicks for Lucid Group

s footprint into Asia Pacific, Africa and Middle East region, and the north west of England, coupled with its highly regarded reputation for scientific content, editorial excellence and digital capability, including
Hanover Health launches the Mackay Programme

Opportunities to work with colleagues in our Brussels, Dublin and Middle East offices.
It’s been altogether more magic for Lucid Group in 2019

This has allowed Lucid to gain new creative and digital capabilities and increase its footprint in the UK, Asia Pacific and Middle East.

More from PMHub
Approximately 0 fully matching, plus 23 partially matching documents found.

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Add my company

The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....